| | |
| Clinical data | |
|---|---|
| Other names | 5-TFM-DMT |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C13H15F3N2 |
| Molar mass | 256.272 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
5-TFM-DMT (5-(trifluoromethyl)-DMT, 5-CF3-DMT, 5-(trifluoromethyl)-N,N-dimethyltryptamine) is a putative psychedelic tryptamine derivative related to drugs such as 5-MeO-DMT, 5-Fluoro-DMT, and 5-TFMO-DMT. It acts as a partial agonist at the 5-HT2A receptor, with an EC50 of 185.7 nM and an efficacy of 28.7% (vs 5-HT), and a full agonist at 5-HT2C with an EC50 of 89.7 nM and an efficacy of 88.8%, and no significant activity at 5-HT2B. [1]
| Tryptamines |
|
|---|---|
| 4-Hydroxytryptamines and esters/ethers |
|
| 5-Hydroxy- and 5-methoxytryptamines |
|
| N-Acetyltryptamines |
|
| α-Alkyltryptamines |
|
| Triptans | |
| Cyclized tryptamines |
|
| Isotryptamines | |
| Related compounds |
|
| | This hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |